ArticleAging2021

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy.

Dongmei Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.